• Home
  • NEW DAY MEDICINE
  • 12 (86) 2025
  • 22 -12 (86) 2025- Abdukodirov E.I., Mirazikova F.Y. - IMPACT OF TUNNEL NEUROPATHIES ON UPPER AND LOWER LIMB FUNCTIONAL CAPACITY IN PARKINSON’S DISEASE AND REHABILITATION STRATEGIES

22 -12 (86) 2025- Abdukodirov E.I., Mirazikova F.Y. - IMPACT OF TUNNEL NEUROPATHIES ON UPPER AND LOWER LIMB FUNCTIONAL CAPACITY IN PARKINSON’S DISEASE AND REHABILITATION STRATEGIES

IMPACT OF TUNNEL NEUROPATHIES ON UPPER AND LOWER LIMB FUNCTIONAL CAPACITY IN PARKINSON’S DISEASE AND REHABILITATION STRATEGIES

Abdukodirov E.I. - Tashkent State Medical University

Mirazikova F.Y. - Tashkent State Medical University

Resume

This article presents a comprehensive investigation of tunnel neuropathies in patients with Parkinson’s disease (PD), evaluating their impact on upper and lower limb functional capacity and the effectiveness of rehabilitation strategies. The study was conducted during 2024–2026 and included 114 PD patients and 20 healthy controls. Using neurological and functional assessment methods (ultrasound, MRI, echography, and clinical testing), the prevalence of tunnel neuropathies, severity of clinical manifestations, muscle strength, gait parameters, balance, and ADL performance were analyzed. The findings indicate that carpal, tarsal, and peroneal tunnel syndromes are highly prevalent in PD and significantly impair fine motor skills, gait speed, and overall functional independence. A 6-week comprehensive rehabilitation program resulted in notable improvements in muscle strength, gait velocity, pain reduction, and ADL independence. Personalized rehabilitation programs play a crucial role in enhancing the quality of life of PD patients with concomitant tunnel neuropathies.

Keywords: Parkinson's disease; tunnel neuropathy; carpal tunnel; tarsal tunnel; peroneal nerve; hand function; leg function; rehabilitation; neurological assessment; ADL.

First page

132

Last page

136

For citation:Abdukodirov E.I., Mirazikova F.Y. - IMPACT OF TUNNEL NEUROPATHIES ON UPPER AND LOWER LIMB FUNCTIONAL CAPACITY IN PARKINSON’S DISEASE AND REHABILITATION STRATEGIES//New Day in Medicine 12(86)2025 132-136 https://newdayworldmedicine.com/en/new_day_medicine/12-86-2025

List of References

  1. Ray Dorsey E, Elbaz A, Nichols E, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis. Lancet Neurol. 2018;17(11):939–953.
  2. Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders. Lancet Neurology. 2020;19(5):459–480.
  3. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–535.
  4. Klingelhoefer L., Reichmann H. Pathogenesis of Parkinson disease—the gut–brain axis and immune system. Nat Rev Neurol. 2015;11:625–636.
  5. Jang JH, Park J, Kim Y. Prevalence of carpal tunnel syndrome in Parkinson’s disease. Parkinsonism Relat Disord. 2018;50:28–33.
  6. Moon H, et al. Motor symptoms and compressive neuropathy in Parkinson’s disease. Clin Neurol Neurosurg. 2019;183:105–115.
  7. Shin HW, Chung SJ. Disturbances of movement in Parkinson's disease and peripheral nerve compression. J Neurol Sci. 2012;323(1-2):32–36.
  8. de Lau LM, Breteler MM. Parkinson disease and peripheral neuropathy. Lancet Neurology. 2014;13(3):345–354.
  9. Toth C, Breithaupt K. Neuropathy in Parkinson disease: electrophysiology and clinical characteristics. Neurology. 2010;75:206–213.
  10. Ceravolo R, et al. Levodopa-induced neuropathy: clinical features and risk factors. J Neurol Neurosurg Psychiatry. 2013;84:564–572.
  11. Palmer S, et al. Rehabilitation for Parkinson’s disease with associated neuropathy: a systematic review. NeuroRehabilitation. 2020;47(1):79–94.
  12. King LA, Horak FB. Impact of physical therapy and exercise on motor symptoms in Parkinson's disease. Mov Disord. 2009;24(S2):S32–S39.

    file

    download